These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21477)
1. Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum. Storb R; Weiden PL; Graham TC; Lerner KG; Nelson N; Thomas ED Transplantation; 1977 Nov; 24(5):349-57. PubMed ID: 21477 [No Abstract] [Full Text] [Related]
2. Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts. Storb R; Raff RF; Appelbaum FR; Schuening F; Sandmaier B; Shulman H; Deeg HJ; Graham T Transplantation; 1988 Jan; 45(1):236-9. PubMed ID: 3276053 [No Abstract] [Full Text] [Related]
3. Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran. Kolb HJ; Storb R; Weiden PL; Ochs HD; Kolb H; Graham TC; Floersheim GL; Thomas ED Biomedicine; 1974 Sep; 20(5):341-51. PubMed ID: 4615750 [No Abstract] [Full Text] [Related]
4. Engraftment of allogeneic dog bone marrow. Vriesendorp HM; Zurcher C; van Bekkum DW Transplant Proc; 1975 Dec; 7(4):465-8. PubMed ID: 825 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG). Kolb HJ; Bodenberger U; Rodt HV; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S Haematol Blood Transfus; 1980; 25():61-71. PubMed ID: 7021361 [No Abstract] [Full Text] [Related]
6. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex. Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888 [TBL] [Abstract][Full Text] [Related]
7. Experimental transplantation and histocompatibility systems in the canine species. Rapaport FT; Bachvaroff RJ Adv Vet Sci Comp Med; 1978; 22():195-219. PubMed ID: 153705 [No Abstract] [Full Text] [Related]
8. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604 [No Abstract] [Full Text] [Related]
9. Antilymphocytic antibodies and marrow transplantation. VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin. Kolb HJ; Rieder I; Rodt H; Netzel B; Grosse-Wilde H; Scholz S; Schäffer E; Kolb H; Thierfelder S Transplantation; 1979 Apr; 27(4):242-5. PubMed ID: 35870 [No Abstract] [Full Text] [Related]
10. Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. Storb R; Kolb HJ; Graham TC; Kolb H; Weiden PL; Thomas ED Blood; 1973 Oct; 42(4):601-9. PubMed ID: 4591632 [No Abstract] [Full Text] [Related]
11. Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Deeg HJ; Storb R; Weiden PL; Shulman HM; Graham TC; Torok-Storb BJ; Thomas ED Blood; 1979 Apr; 53(4):552-7. PubMed ID: 371633 [No Abstract] [Full Text] [Related]
12. Cyclosporin-A abrogates transfusion-induced sensitization and prevents marrow graft rejection in DLA-identical canine littermates. Storb R; Deeg HJ; Atkinson K; Weiden PL; Sale G; Colby R; Thomas ED Blood; 1982 Aug; 60(2):524-6. PubMed ID: 7046849 [TBL] [Abstract][Full Text] [Related]
13. The effect of buffy coat-poor blood transfusion on subsequent hemopoietic grafts. Storb R; Kolb HJ; Graham TC; Erickson V; Thomas ED Transplantation; 1973 Jan; 15(1):129-36. PubMed ID: 4145720 [No Abstract] [Full Text] [Related]
14. Marrow graft rejection in DLA-identical canine littermates: antigens involved are expressed on leukocytes and skin epithelial cells but probably not on platelets and red blood cells. Storb R; Deeg HJ; Weiden PL; Graham TC; Atkinson KA; Slichter SJ; Thomas ED Transplant Proc; 1979 Mar; 11(1):504-6. PubMed ID: 377686 [No Abstract] [Full Text] [Related]
15. Use of antithymocyte serum in clinical and experimental marrow transplantation. Storb R; Weiden PL; Thomas ED Postgrad Med J; 1976; 52(5 Suppl):96-103. PubMed ID: 11456 [TBL] [Abstract][Full Text] [Related]
16. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion. Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation in the busulfin-treated rat. III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients. Tutschka PJ; Santon GW Transplantation; 1977 Jul; 24(1):52-62. PubMed ID: 18820 [No Abstract] [Full Text] [Related]
18. The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates. Storb R; Raff RF; Appelbaum FR; Schuening FW; Sandmaier BM; Graham TC Transplantation; 1988 Aug; 46(2):334-6. PubMed ID: 3043788 [No Abstract] [Full Text] [Related]
19. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum. Weiden PL; Storb R; Slichter S; Warren RP; Sale GE J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593 [TBL] [Abstract][Full Text] [Related]
20. The double barrier in bone marrow transplantation. van Bekkum DW Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846 [No Abstract] [Full Text] [Related] [Next] [New Search]